PORTLAND, Ore.--(BUSINESS WIRE)--June 9, 2005--AVI BioPharma, Inc. (Nasdaq:AVII), today announced that Alan P. Timmins, AVI’s president and COO, will testify before the U.S. Senate Committee on Health, Education, Labor and Pensions Subcommittee on Bioterrorism and Public Health Preparedness. The hearing will examine the challenges of bringing to the fore promising new medical treatments to address bioterror and other public health threats.
